- Bloomberg via Yahoo FinanceJun 17 13:30 PM
The company announced Monday morning that it’s paying almost $11 billion for cancer drugmaker Array Biopharma Inc. The deal would bolster Pfizer’s cancer portfolio and add medicines that ...
- Market Watch2 days ago
2019 Report: Cancer Supportive Care Drugs Market by Top Players Analysis - Amgen, Helsinn Healthcare SA, Heron TherapeuticsMarket Watch5 days ago
- Bloomberg via Yahoo Finance3 days ago
- Zacks via Yahoo FinanceJun 19 13:06 PM
In a surprising move, on Monday, drug giant, Pfizer PFE announced a definitive agreement to buy small cancer drugmaker, Array BioPharma ARRY for $48 per share in cash for a total enterprise ...
- Zacks via Yahoo FinanceJun 18 12:59 PM
AstraZeneca plc. AZN and partner Merck MRK announced that the European Commission (EC) has granted marketing approval to their PARP inhibitor Lynparza for first-line maintenance treatment of BRCA-mutated advanced ovarian cancer.